The slip
PARKINSON RECEIPTno. 9188
25 Oct 2026, 01:10 UTCdopamine neurons, braak
predictionTRAPPC13 in dopamine neurons tracks Braak Lewy-body stage
registered014b22fa4a190d6c
discovery-0.47 p=0.197 n=9
replication+0.04 p=0.911 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.47, p 0.197)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT5d0b6413ec9d39a76fd47b1c…
follows 27deb7a0ad5c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9188: TRAPPC13 in dopamine neurons, braak
- power
- full sample -0.26 (p 0.298, n 18), 95% CI -0.65 to +0.24. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.29 (p 0.243, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.31 (p 0.204, n 18). could be the mix.
- skeptic
- leave-one-out range -0.38 to -0.15, sign flips 0; without severely affected donors -0.26 (p 0.298, n 18). fragile.
- cell type
- strongest in OPCs: -0.59 (p 0.0096, n 18) vs -0.26 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TRAPPC13 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TRAPPC13 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.30 p 0.286 (needs p < 2.3e-4)